The Many Names of Fatty Liver Disease: Strengths and Limitations of Metabolic (Dysfunction)-Associated Fatty Liver Disease
- 1 January 2023
- journal article
- editorial
- Published by Mary Ann Liebert Inc in Childhood Obesity
- Vol. 19 (1), 1-2
- https://doi.org/10.1089/chi.2022.0104
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statementThe Lancet Gastroenterology & Hepatology, 2021
- From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—New Terminology in Pediatric Patients as a Step in Good Scientific Direction?Journal of Clinical Medicine, 2021
- NAFLD to MAFLD in adults but the saga continues in children: an opportunity to advocate changeJournal of Hepatology, 2021
- Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and ChallengesGastroenterology, 2020
- NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in ChildrenJournal of Pediatric Gastroenterology and Nutrition, 2017
- Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomesJournal of Hepatology, 2015
- Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver diseaseThe Journal of Pediatrics, 2003